CREDIT SUISSE AG/ - BIOSPECIFICS TECHNOLOGIES CO ownership

BIOSPECIFICS TECHNOLOGIES CO's ticker is BSTC and the CUSIP is 090931106. A total of 88 filers reported holding BIOSPECIFICS TECHNOLOGIES CO in Q4 2017. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
CREDIT SUISSE AG/ ownership history of BIOSPECIFICS TECHNOLOGIES CO
ValueSharesWeighting
Q3 2020$300,000
-21.9%
5,678
-9.6%
0.00%
Q2 2020$384,000
+55.5%
6,278
+58.7%
0.00%
Q1 2019$247,000
+0.8%
3,957
-24.7%
0.00%
Q3 2017$245,000
-31.6%
5,258
-19.5%
0.00%
Q1 2017$358,000
-31.5%
6,534
-30.4%
0.00%
-100.0%
Q4 2016$523,000
+5.7%
9,385
-13.5%
0.00%
Q3 2016$495,000
+20.4%
10,847
+5.5%
0.00%
Q2 2016$411,000
+90.3%
10,279
+66.1%
0.00%
Q1 2016$216,000
-37.4%
6,189
-22.9%
0.00%
Q4 2015$345,000
+23.2%
8,025
+47.8%
0.00%
Q2 2015$280,0005,4280.00%
Other shareholders
BIOSPECIFICS TECHNOLOGIES CO shareholders Q4 2017
NameSharesValueWeighting ↓
Stonepine Capital Management, LLC 285,259$16,685,0009.76%
JW Asset Management, LLC 73,649$4,308,0002.32%
THB ASSET MANAGEMENT 113,485$6,637,0000.81%
Eversept Partners, LP 21,900$1,280,9310.56%
EAM Global Investors LLC 20,642$1,207,0000.49%
RICE HALL JAMES & ASSOCIATES, LLC 181,690$10,627,0000.38%
Elk Creek Partners, LLC 114,230$6,681,0000.36%
ISTHMUS PARTNERS, LLC 19,525$1,142,0000.29%
PURA VIDA INVESTMENTS, LLC 20,160$1,179,0000.25%
CADENCE CAPITAL MANAGEMENT LLC 49,363$2,887,0000.16%
View complete list of BIOSPECIFICS TECHNOLOGIES CO shareholders